Taylor P.
About Taylor P.
Taylor P. is a Senior Scientist in Process Development at Notch Therapeutics in Toronto, Ontario, with a strong background in biotechnology and oceanography. They have extensive experience in cell culture and manufacturing sciences, having worked at various institutions including AbbVie and Mustang Bio.
Work at Notch Therapeutics
Taylor P. has been employed at Notch Therapeutics as a Senior Scientist in Process Development since 2021. In this role, Taylor focuses on the development of manufacturing processes, particularly in the context of cell differentiation. The position is based in Toronto, Ontario, Canada, where Taylor has been contributing to advancements in biotechnology for three years.
Education and Expertise
Taylor P. holds a Master of Science (M.S.) in Biotechnology from Worcester State University and a Bachelor of Science (B.S.) in Biotechnology from the same institution. Additionally, Taylor studied Chemical and Physical Oceanography at the University of Rhode Island. This educational background supports Taylor's expertise in scaling up processes for cell differentiation, especially related to induced pluripotent stem cells (iPSC) and T cell research.
Background
Taylor P. has a diverse professional background in the biotechnology and life sciences sectors. Prior to joining Notch Therapeutics, Taylor worked in various roles, including as a Senior Engineer at Vor Biopharma and as a Principal Scientist at Mustang Bio. Taylor's experience includes internships at the University of Massachusetts Medical School and the University of Rhode Island, where foundational skills in neurobiology and research were developed.
Achievements
In the course of Taylor P.'s career, significant contributions have been made to the field of biotechnology. Taylor has been involved in the development of procedures for manufacturing processes, particularly through the design and execution of experiments focused on iPSC expansion and T cell differentiation. Notably, Taylor contributed to a publication detailing the high yield and purity differentiation of human induced pluripotent stem cells to hematopoietic progenitor cells in a scalable stirred tank bioreactor.